By HotStockRockets | Thursday 28 July 2016
Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Good news. This is the sort of thing investors have been wanting Optibiotix (OPTI) to announce and it is delivering. The company says that the trial launch of its Slimbiome® ingredients in a range of meal replacement shakes and natural snack bars went well. In independent tests the ingredients of bars and drinks including Slimbiome showed fatties cutting calorie intakes by 20% or more and suffering fewer cravings.
Hence, having worked with it on the trial, Optibiotix has now acquired 51% of a jv with The Healthy Weight Loss Company and states that "Retail listings have been confirmed with first listings on the shelves from August, and wider discussions taking place." Optibiotix notes that "Early web based sales are out-performing expectations, and the products are receiving positive reviews and most importantly, dieters are finding the real benefits of this diet plan".
Good! This means near term revenues and possibly a rapid ramp up if Optibiotix gets big name listings for Slimbiome. And of course this is just one product of many. There will be a lot more news of this sort in the pipeline.
The shares are ahead today at 80p to 83p but do not sell. Hang on for more, we expect a flurry of announcements in the coming eight weeks, including one on a major spin-off and that should push the shares easily past the 100p mark. Hang on for that.
Never miss a story.
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Comments are turned off for this article.
Search ShareProphets |
Stock market news |
Recent Comments |